Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 31;13(1):241.
doi: 10.3390/jcm13010241.

Clinical Manifestations and Management of Fibrotic Pulmonary Sarcoidosis

Jin Sun Kim  1 , Rohit Gupta  2
Affiliations
Review

Clinical Manifestations and Management of Fibrotic Pulmonary Sarcoidosis

Jin Sun Kim et al. J Clin Med. .

Abstract

Fibrotic pulmonary sarcoidosis represents a distinct and relatively uncommon manifestation within the spectrum of sarcoidosis and has substantial morbidity and mortality. Due to the scarcity of research focused on this specific disease subtype, our current understanding of pathogenesis and optimal management remains constrained. This knowledge gap underscores the need for further investigation into areas such as targeted therapies, lung transplantation, and quality of life of patients with fibrotic pulmonary sarcoidosis. The primary aim of this review is to discuss recent developments within the realm of fibrotic pulmonary sarcoidosis to foster a more comprehensive understanding of the underlying mechanisms, prognosis, and potential treatment modalities.

Keywords: advanced pulmonary sarcoidosis; fibrotic pulmonary sarcoidosis; pulmonary fibrosis; sarcoidosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Drivers that may be involved in fibrotic pulmonary sarcoidosis. GREM1, gremlin 1; TLR3, toll-like receptor 3; ANXA11, annexin 11; Tregs, T-regulatory cells; Th17, T-helper 17 cells; mTOR, mammalian target of rapamycin complex 1; HIF1α, hypoxia inducible factor 1; CCL-18, C-C motif chemokine ligand 18.
Figure 2
Figure 2
Images of three patients with advanced pulmonary sarcoidosis: patient 1 with biapical cavities and mycetoma (asterisk) on chest X-ray (A), large biapical bronchiectatic cavities (arrows) on coronal image of CT chest (B), right apical mycetoma (asterisk) and extensive left-sided upper-zone predominant fibrosis (arrow head) of anterior lung on axial image of CT chest (C); patient 2 with enlarged pulmonary artery diameter (45 mm) on axial image of CT chest (D); patient 3 with bilateral irregular reticular and nodular fibrosis (arrow head) on coronal image of CT chest (E) with air trapping (arrow) on axial image of CT chest (F).
Figure 3
Figure 3
FDG-PET/CT imaging of a 68-year-old male with fibrotic pulmonary sarcoidosis on chronic methotrexate with metabolically active infiltrates (arrows) in the right upper lobe and left upper lobe extending into the pleura (A,B); reduced density and activity on follow-up imaging 12 months after the addition of anti-TNF-alpha inhibitor (C,D).
Figure 4
Figure 4
Simplified algorithm for the management of fibrotic pulmonary sarcoidosis. *Investigations with pulmonary function test, 6-min walk test, high-resolution computed tomography, echocardiogram, and fluorodeoxyglucose positron emission tomography integrated with computed tomography.
See this image and copyright information in PMC

References

    1. Hunninghake G.W., Costabel U., Ando M., Baughman R., Cordier J.F., Bois R.D., Eklund A., Kitaichi M., Lynch J., Rizzato G., et al. Ats/ers/wasog statement on sarcoidosis. American thoracic society/european respiratory society/world association of sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc. Diffuse Lung Dis. 1999;16:149–173. - PubMed
    1. Judson M.A., Thompson B.W., Rabin D.L., Steimel J., Knattereud G.L., Lackland D.T., Rose C., Rand C.S., Baughman R.P., Teirstein A.S., et al. The diagnostic pathway to sarcoidosis. Chest. 2003;123:406–412. doi: 10.1378/chest.123.2.406. - DOI - PubMed
    1. Crouser E.D., Maier L.A., Wilson K.C., Bonham C.A., Morgenthau A.S., Patterson K.C., Abston E., Bernstein R.C., Blankstein R., Chen E.S., et al. Diagnosis and detection of sarcoidosis. An official american thoracic society clinical practice guideline. Am. J. Respir. Crit. Care Med. 2020;201:e26–e51. doi: 10.1164/rccm.202002-0251ST. - DOI - PMC - PubMed
    1. Baughman R.P., Lower E.E., Bois R.M.D. Sarcoidosis. Lancet. 2003;361:1111–1118. doi: 10.1016/S0140-6736(03)12888-7. - DOI - PubMed
    1. Hena K.M. Sarcoidosis epidemiology: Race matters. Front. Immunol. 2020;11:537382. doi: 10.3389/fimmu.2020.537382. - DOI - PMC - PubMed

LinkOut - more resources